Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

income that have a significant positive or negative impact on results yet

do not occur on a consistent or regular basis in its business. In

determining whether a particular item meets one of these criteria,

management considers facts and circumstances that it believes are

relevant. Management believes that excluding such charges and income from

income or loss allows investors and management to evaluate and compare the

Company's operating results from continuing operations from period to

period in a meaningful and consistent manner. Due to the frequency of

their occurrence in its business, the Company does not adjust net income

or loss for the costs associated with litigation, including payments made

or received through settlements. It should be noted that "net income or

loss on an adjusted cash basis" is not a standard financial measurement

under accounting principles generally accepted in the United States of

America ("GAAP") and should not be considered as an alternative to net

income or loss or cash flow from operating activities, as a measure of

liquidity or as an indicator of operating performance or any measure of

performance derived in accordance with GAAP.

(b) Amortization expense of $95.0 million and $16.6 million in the first

six months of 2008 and 2007 GAAP results, respectively, including $23.7

million and $6.3 million charged to cost of sales, $1.8 million and $1.5

million charged to research and development and $69.1 million and $8.6

million charged to selling, general and administrative, in the respective

periods, with $0.4 million and $0.2 million charged through equity

earnings of unconsolidated entities, net of tax during the six months

ended June 30, 3008 and 2007, respectively.

(c) Restructuring charges associated with the decision to close facilities

of $39.9 million and $1.0 million in
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Crystal Diagnostics (CDx) Xpress System, ... has received AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing ... collectively referred to as STEC or the “Big-6”) as well ... unit (cfu) per 325 g of raw ground beef and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... CAMBRIDGE, Mass. , Jan. 22, 2015   GenoSpace , ... suite of tools to enable the broad use of genomic, ... today announced the appointment of Michelle Munson , CEO ... independent director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... 20. Juni 2008 / b3c newswire / ... Herstellung moderner biopharmazeutischer Arzneimittel gibt die Inbetriebnahme ... das Unternehmen nun über neun unabhängige GMP-Produktionslinien ... 2.500 Litern für die Herstellung von klinischen ...
... DEARBORN, Mich., June 20 The United States Council ... Ford Motor,Company and General Motors Corporation, welcomed the addition ... as announced by,the U.S. Department of Energy (DOE) today ... Mich., DTE Energy and Southern California Edison were ...
... for Sales and Clinical Services, ST. LOUIS, ... that it has enhanced its senior management team ... appointment of Louis,Ruggiero as Senior Vice President, North ... Marketing Officer at DJ Orthopedics, formerly was,President and ...
Cached Biology Technology:Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen 2U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 2U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 3U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 4Stereotaxis Appoints Senior Vice President, North America 2Stereotaxis Appoints Senior Vice President, North America 3
(Date:12/17/2014)... Va. , Dec. 15, 2014 The Defense ... easier to detect and prevent counterfeit microcircuits from entering ... started performing an in-house microcircuit anti-counterfeit initiative dubbed DNA ... microcircuits while increasing their reliability throughout the supply chain. ...
(Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
(Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... million tons of plastic are placed in U.S. landfills each ... that some of the largely petroleum-based plastic may soon be ... the carbon footprint and the dependence on foreign oil, this ... for farmers. "Making plastics from plants is not a ...
... and Technology (NIST) has developed a new certified ... assurance tool for measuring the amounts of vitamins, ... new Standard Reference Material (SRM) 3280 for multivitamin/multimineral ... of Dietary Supplements (ODS) at the National Institutes ...
... species of lice that infest humans: pubic lice, Pthirus ... humanus . A new article in BioMed Central,s open access ... separation of the two species. In the ... was struck by inspiration while pondering the question of why ...
Cached Biology News:'Green' plastics could help reduce carbon footprint 2New reference material can improve testing of multivitamin tablets 2
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
... ( Abpromise for all tested applications). ... KLH derived from within residues 1 - 100 ... sequence is proprietary) (Peptide available ... Gene ID: 5453 Swiss ...
ATP-binding cassette sub-family D member 4 (Peroxisomal membrane protein 69) (PMP69) (Peroxisomal membrane protein 1-like) (PXMP1-L) (P70R). [Source:Uniprot/SWISSPROT;Acc:O14678] Antigen: Recombi...
Biology Products: